You just read:

Cell Therapeutics, Inc. (CTI) Readies Pixuvri® European Launch and Start of Pacritinib Phase 3 Trial; Reports Second Quarter Financial Results and Milestones

News provided by

Cell Therapeutics, Inc.

Aug 01, 2012, 01:30 ET